Results 101 to 110 of about 9,438,737 (154)

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. [PDF]

open access: yesBr J Cancer, 2012
Kämpjärvi K   +18 more
europepmc   +1 more source

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium. [PDF]

open access: yesBreast Cancer Res, 2016
Muranen TA   +43 more
europepmc   +1 more source

An association study between CHEK2 gene mutations and susceptibility to breast cancer. [PDF]

open access: yesComp Clin Path, 2017
Jalilvand M   +6 more
europepmc   +1 more source

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications. [PDF]

open access: yesBreast Cancer Res, 2011
Muranen TA   +9 more
europepmc   +1 more source

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. [PDF]

open access: yesJ Pathol Clin Res, 2015
Howat WJ   +51 more
europepmc   +1 more source

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. [PDF]

open access: yesNat Genet, 2020
Fachal L   +346 more
europepmc   +1 more source

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. [PDF]

open access: yesJ Clin Oncol, 2012
Weischer M   +68 more
europepmc   +1 more source

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. [PDF]

open access: yesAm J Hum Genet, 2019
Mavaddat N   +271 more
europepmc   +1 more source

Genome-wide association study of germline variants and breast cancer-specific mortality. [PDF]

open access: yesBr J Cancer, 2019
Escala-Garcia M   +236 more
europepmc   +1 more source

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. [PDF]

open access: yesCarcinogenesis, 2014
Purrington KS   +108 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy